A new joint report, ‘State of the Discovery Nation 2018’ by the Medicines Discovery Catapult and the BioIndustry Association, has been launched by Sir Mark Walport to provide unique insights into the productivity of the UK’s drug discovery community, and the challenges and opportunities it faces.

Ingenza has joined forces with leading universities and industrial partners to participate in the ConBioChem collaboration, a translational project focused on the development of novel platform technologies for the continuous bio-production of commodity chemicals.

Sterilisation specialist Astell Scientific has released its latest Remote Management/Diagnosis product option, enabling secure network connectivity, remote access, and diagnostics on any of its compatible circular or square section autoclaves.

Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published list from news journal Business in Vancouver (BIV).

SpeeDx Pty. Ltd, a developer of advanced multiplex molecular diagnostic solutions, announced the incorporation of a US-based subsidiary company, SpeeDx Inc. It will use the US base to support current clinical trial activity for ResistancePlus™ MG in preparation for an expected 2018 launch.

A pioneering method of delivering lifesaving drugs using microbubbles is one step closer to being used in patients, as a new research project begins today.